eIF3 γ Antibodies

Santa Cruz Biotechnology delivers a wide array of eIF3 γ monoclonal antibodies for investigating the role of this essential translation factor. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF3 γ is a critical component of the eukaryotic translation initiation factor 3 complex, playing a vital role in the regulation of protein synthesis. It is involved in the recruitment of mRNA and the ribosomal subunit, making it essential for the initiation of translation. Dysregulation of eIF3 γ has been implicated in various diseases, including cancer, highlighting its importance as a target for therapeutic intervention. Research has shown that eIF3 γ interacts with multiple cellular pathways and signaling cascades. Understanding eIF3 γ function and regulation can provide valuable insights into fundamental cellular processes. Recent studies have revealed new roles for eIF3 γ in cell cycle regulation and stress response. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of eIF3 γ's role in health and disease.